Topic filter : Pfizer

Most trending topics in Business & Finance ( last 24 hours ):
Student Halifax Employee McDonald Home Owner Interest Rate Mis-sold Fraud Class-action Lawsuit Scammer Legal Action Broadband TalkTalk Railway More Expensive Bargain Pound Euro Commuter Brexit First-time Buyer Isa Election Airline Holiday

Socially Most Trending News

.... The march towards annual revenues of $45bn (£34. 5bn) by 2023, the target set when Pfizer’s takeover offer was rebuffed three years ago, would begin in earnest. ... [Read full article on Guardian ]
Thursday 27th of July 2017 03:19:10 PM
Total Trend count
610
Most trending on :
610
.... Imfinzi is already approved for bladder cancer in the US. The study forms a key part of Soriot’s promise to rebuild the company’s drugs pipeline and boost revenues to $45bn by 2023, after rejecting a $118bn (£69bn) takeover bid from US rival Pfizer in 2014. ... [Read full article on Guardian ]
Thursday 27th of July 2017 07:36:16 AM
Total Trend count
61
Most trending on :
61

Latest Finance News related to Pfizer

AstraZeneca boss Pascal Soriot's 'pivotal' year is turning out horribly | Nils Pratley image
.... The march towards annual revenues of $45bn (£34. 5bn) by 2023, the target set when Pfizer’s takeover offer was rebuffed three years ago, would begin in earnest. ...
AstraZeneca shares dive after failure in key lung cancer drug trial image
Source : Guardian [Read Article] Thursday 27th of July 2017 07:36:16 AM
.... Imfinzi is already approved for bladder cancer in the US. The study forms a key part of Soriot’s promise to rebuild the company’s drugs pipeline and boost revenues to $45bn by 2023, after rejecting a $118bn (£69bn) takeover bid from US rival Pfizer in 2014. ...
Post-Brexit London is open for business (no matter how grubby) image
Source : Guardian [Read Article] Thursday 13th of July 2017 06:21:05 PM
.... Then there’s the fact that 2017 is supposed to be the pivotal year for AstraZeneca. The results of a critical trial on a potential blockbuster lung cancer treatment are due soon, setting the stage for the company to prove it was right to reject Pfizer’s takeover bid in 2014 and back its long-term standalone prospects. ...
Post-Brexit EU drug regulation deal urged by ministers image
Source : BBC [Read Article] Tuesday 4th of July 2017 06:50:52 AM
....The UK pharmaceuticals trade association has also warned that Brexit could undermine future investment, research and jobs in the country. But speaking on the BBC's Today programme, the UK managing director of US drugs giant Pfizer, Erik Nordkamp, said there were other issues than Brexit that the industry wanted to see addressed. ...
Pfizer to give out breast cancer drug free while awaiting NHS decision image
....A drug described as one of the most important advances in treating breast cancer in the past 20 years is to be given to women in the UK for free while the medicines regulator decides whether it should be available on the NHS. The National Institute for Health and Care Excellence’s provisional decision in February that palbociclib should not be routinely funded on the NHS in England was decried by patients but its final appraisal has been paused for the drug manufacturer Pfizer to present further clinical data. ...
Will Lloyds chief enjoy plain sailing or will he jump ship? | Nils Pratley image
.... The company’s drug pipeline is widely regarded as one of the best in the business, especially in oncology, but promise and hard success are not the same thing. AstraZeneca’s share price is still well below the level at which Pfizer bid in 2014. ...
Donald Trump’s tax holiday 'would help top US companies save $300bn' image
Source : Guardian [Read Article] Wednesday 12th of April 2017 04:00:25 AM
....5bn in tax by taking advantage of Trump’s one-off 10% repatriation tax. Other companies sitting on vast fortunes parked offshore include the drugs maker Pfizer, with $193bn, Microsoft, with $124bn, and GM, with $104bn. ...
Unilever is safe, but we need better defences against short-term capitalism image
....Yet that line is too simplistic, for the reasons Theresa May gave in her speech launching her leadership campaign last summer. “As we saw when Cadbury’s – that great Birmingham company – was bought by Kraft, or when AstraZeneca was almost sold to Pfizer, transient shareholders, who are mostly companies investing other people’s money, are not the only people with an interest when firms are sold or close,” she said. ...
UK government should help companies targeted by foreign bids, says Unilever image
.... Theresa May has previously said the government should have more powers to block predatory bids for companies in important industries for the economy. The prime minister has indicated she would have blocked Kraft’s takeover of Cadbury in 2010 and Pfizer’s failed attempt to buy pharmaceuticals group AstraZeneca. ...
UK pharma firms accused of illegal deals to hike price of life-saving drug image
....The investigation is part of a wider clampdown by the regulator on the pharmaceutical industry. It fined Pfizer a record £84. ...
NHS 'overcharged' by drug makers' non-compete deal, says CMA image
Source : BBC [Read Article] Friday 3rd of March 2017 08:39:04 AM
.... . Earlier that month, Pfizer and Flynn Pharma were fined nearly £90m for raising the price of an anti-epilepsy treatment, although both firms said they would appeal. ...
UK plans draft response to foreign takeovers after failed Unilever bid image
Source : Guardian [Read Article] Wednesday 22nd of February 2017 03:07:18 PM
.... However, a week earlier in her campaign speech shortly before she became prime minister, May signalled a willingness to take a more interventionist role in foreign takeovers. She highlighted Kraft’s takeover of Cadbury’s, and Pfizer’s failed bid for AstraZeneca, as examples of deals that could have benefited from closer government scrutiny. ...
Theresa May must take £115bn hint from Kraft Heinz's failed Unilever bid image
Source : Guardian [Read Article] Monday 20th of February 2017 07:33:19 PM
.... The time is ripe to insist that mega-bids of this type should pass a public interest test. Last July, in her campaign to secure the Tory leadership, May seemed keen on the idea when she cited Pfizer’s failed tilt at AstraZeneca in 2014 and declared: “A proper industrial strategy wouldn’t automatically stop the sale of British firms to foreign ones, but it should be capable of stepping in to defend a sector that is as important as pharmaceuticals is to Britain. ...
Drugs firms are accused of putting cancer patients at risk over price hikes image
Source : Guardian [Read Article] Saturday 28th of January 2017 02:54:55 PM
....5bn. The multinational Pfizer was fined £84m in the UK in December for conspiring with a generic company, Flynn Pharma, to raise the price paid by the NHS by 2,600% for an anti-epilepsy drug that came off-patent. ...
Japan's Takeda buys US cancer specialist Ariad for $5.2bn image
Source : BBC [Read Article] Tuesday 10th of January 2017 03:37:56 AM
....Cancer drugs are appealing to large pharmaceutical firms, who are prepared to pay high prices for companies with promising products in the pipeline. This was demonstrated in August, when San Francisco-based Medivation was bought by Pfizer Inc for $14bn. ...
FTSE falters but Royal Bank of Scotland rises after Deutsche Bank deal image
Source : Guardian [Read Article] Friday 23rd of December 2016 09:51:02 AM
Drugs firms face fresh questions after Actavis accused of 12,000% price hike image
....Drugs companies are facing renewed questions about the prices they charge the NHS for life-saving medicines after a firm was accused of marking up a tablet by more than 12,000%. A week after US giant Pfizer was slapped with a record fine of £84. ...
Actavis UK accused of overcharging NHS for vital drug image
Source : BBC [Read Article] Friday 16th of December 2016 07:32:35 AM
....The competition watchdog has been clamping down on drugs companies for overcharging the NHS. Earlier in December, the CMA fined Pfizer a record £84. ...
Wall Street: Dow Jones and S&P 500 hit fresh records image
Source : BBC [Read Article] Wednesday 7th of December 2016 10:45:10 PM
.... However, healthcare was a big loser after Trump said he wanted to bring down prescription prices. Pfizer fell more than 1% and Celgene lost 4%. ...
AstraZeneca to move some UK jobs to Poland, Costa Rica and Malaysia image
Source : Guardian [Read Article] Sunday 4th of December 2016 01:26:06 PM
....That came a year after the company axed 7,300 jobs in an earlier drive to reduce costs. The security of AstraZeneca’s workforce was an important issue two years ago when the company successfully fought off a takeover attempt from its US rival Pfizer. ...
GSK's Andrew Witty: the man who sold the world cheaper medicines image
Source : Guardian [Read Article] Friday 2nd of December 2016 07:00:09 AM
....And Médecins Sans Frontières criticised the index for highlighting some good practice among pharma companies that served to hide their failings. GSK and Pfizer had just dropped the price of their pneumococcal vaccine for use in emergencies but continued to charge high prices to middle-income countries, it said. ...
Corporate winners from Donald Trump’s election image
Source : Guardian [Read Article] Thursday 10th of November 2016 06:13:59 PM
....Clinton’s policy on drug pricing was mostly a reaction to the success of rival Bernie Sanders’ popular message. Shares in Pfizer, the world’s biggest drugmaker, have risen by 10% since the result of the election became clear. ...
AstraZeneca chief: US healthcare set for big changes under Trump image
Source : Guardian [Read Article] Thursday 10th of November 2016 02:22:21 PM
.... Other trials are continuing, and data on a combination with another new drug, tremelimumab, to treat lung cancer are expected in the first half of next year. Soriot remains under pressure to deliver, following the board’s rejection of a £69bn takeover offer from Pfizer in 2014. ...
Business winners and losers from a Donald Trump presidency image
Source : Guardian [Read Article] Wednesday 9th of November 2016 04:25:51 PM
Pfizer jobs at risk over UK sites closure plan image
Source : BBC [Read Article] Wednesday 9th of November 2016 10:02:33 AM
. More than 370 jobs are at risk after the US drugs giant Pfizer announced plans to shut two of its UK sites. ...
A slice of the pie image
Source : BBC [Read Article] Wednesday 7th of September 2016 03:34:13 PM
EpiPen maker to sell cheaper generic version image
Source : BBC [Read Article] Monday 29th of August 2016 03:58:22 PM
.... . Other drug makers including Valeant, Turing and Pfizer have come under fire in recent months for sharp price increases. ...
Pfizer to buy cancer drug firm Medivation for $14bn image
Source : BBC [Read Article] Monday 22nd of August 2016 01:02:09 AM
. The US pharmaceutical giant Pfizer has confirmed that it will buy a US cancer drug firm, Medivation, for about $14bn (£10. ...
Carl Icahn buys stake in Botox-maker Allergan image
Source : Guardian [Read Article] Tuesday 31st of May 2016 11:17:35 PM
....Allergan said it had “no reason to believe” Icahn wants to influence management or control the company. The investment comes after the Irish company and US drugmaker Pfizer scrapped plans to combine in a $160bn deal, after the US Treasury Department created rules aimed at blocking American companies from moving corporate addresses overseas to reduce their domestic tax bills. ...
US corporate giants hoarding more than a trillion dollars image
Source : Guardian [Read Article] Friday 20th of May 2016 06:04:00 PM
.... “Since Apple became the cash king in 2009, its $176 bn increase represents 26% of the total $670bn increase in corporate cash over the same period,” Moody’s said. The biggest cash pile held by a non-tech company is the $39bn in the coffers of pharmaceutical company Pfizer. ...
AstraZeneca climbs after positive asthma treatment results image
Source : Guardian [Read Article] Tuesday 17th of May 2016 10:07:34 AM
....The company has previously suggested Benralizumab could reach annual sales of around $2bn, which would give a real boost to its drugs portfolio. It had made the sales forecast as part of its defence against the unwanted takeover attempt by Pfizer. ...
Pfizer to buy Anacor in $5.2bn deal for access to eczema gel image
Source : Guardian [Read Article] Monday 16th of May 2016 06:49:07 PM
Pfizer death penalty drug decision welcomed by activists but states fight on image
.... He grew dizzy, snorted, dropped his head to the pillow on the gurney and took his last breaths. Related: Pfizer blocks its drugs from being used in lethal injections in prisons. ...
Brexit ‘will put UK access to cutting-edge medicines at risk’ image
Source : Guardian [Read Article] Saturday 7th of May 2016 07:50:14 PM
....British people benefit at the earliest opportunity from the best medicines produced by “cutting-edge” research because the UK is part of the EU, 93 business leaders and organisations from the life-sciences industry say. The group, which includes executives from the top trio of companies – GlaxoSmithKline, AstraZeneca and Pfizer – says EU funding for research and Europe-wide regulations help produce new, more effective drugs more quickly. ...
A tough gig for Sainsbury’s Coupe image
Source : Guardian [Read Article] Sunday 1st of May 2016 08:00:50 AM
....Shareholders are being urged to use the gathering to put pressure on Glaxo to lower the price of its life-saving pneumonia vaccines. Médecins Sans Frontières (MSF) has just delivered a petition to Glaxo (and another to rival Pfizer) asking that the vaccine prices be cut to $5 for each child in developing countries. ...
AstraZeneca focuses on cancer treatments as profits slide image
Source : Guardian [Read Article] Friday 29th of April 2016 09:00:18 AM
....At its AGM in London on Friday afternoon, the drugmaker is likely to face questions from shareholders over why it has not linked the pay of its chief executive to the ambitious sales target of £45bn by 2023, up from $26bn last year. Soriot announced the goal when he was fighting off a £70bn takeover bid from its US rival Pfizer two years ago. ...
Shareholders urged to push for cheaper pneumonia drugs image
Source : Guardian [Read Article] Wednesday 27th of April 2016 08:22:34 PM
. Shareholders are being urged to use the annual general meetings of Pfizer and GlaxoSmithKline to put pressure on the companies to lower the price of their life-saving pneumonia vaccines. ...
AstraZeneca slips on talk of possible £7bn bid for US cancer specialist image
.... Shore Capital’s Dr Tara Raveendran said:. A bid for the company would fit with AstraZeneca’s recent strategic focus on oncology, with durvalumab, Lynparza and Tagrisso expected to collectively earn $12bn per annum in sales by 2023F a significant proportion of the $45bn target set by chief executive Pascal Soriot following the Pfizer-bid. ...
US corporations have $1.4tn hidden in tax havens, claims Oxfam report image
Source : Guardian [Read Article] Thursday 14th of April 2016 04:01:07 AM
....Boston-based conglomerate General Electric, which Oxfam said has received $28bn in taxpayer backing, was second with $119bn stored in 118 tax haven subsidiaries. Computing firm Microsoft was third with $108bn, in a top 10 that also included pharmaceuticals giant Pfizer, Google’s parent company Alphabet and Exxon Mobil, the largest oil company not owned by an oil-producing state. ...
If you're rich, you can avoid paying taxes. That's got to change | Jan Schakowsky image
.... It would also effectively limit the tax benefits of corporate inversions by treating foreign corporations managed and controlled in the US as domestic corporations for tax purposes. Pfizer apparently tried to structure one such inversion deal with the Irish company Allergan, shifting its headquarters from the US to Ireland. ...
FTSE 100 falls despite M&S boost image
Source : BBC [Read Article] Thursday 7th of April 2016 11:26:08 AM
....20p after Credit Suisse lifted its rating on the company to "outperform" from "underperform", and also raised its share price target to 290p from 240p. Drugmakers AstraZeneca and Shire were trading higher as speculation continued about future deals in the sector following the collapse of Pfizer's merger with Allergan. ...
The super rich live in a parallel world; here's how we bring them back to reality image
.... Barack Obama has promised reforms and even implemented some. This week US drug company Pfizer’s mega merger with Ireland’s Allergan collapsed thanks to Obama’s tightening of the rules around US companies doing such deals in order to escape US taxes. ...
FTSE climbs on Fed comments and oil rise, but Pearson slides image
Source : Guardian [Read Article] Thursday 7th of April 2016 08:37:14 AM
....AstraZeneca has added 75p to 4202. 5p in the wake of the collapse of Pfizer’s $160bn deal to buy Allergan, as investors tried to decide where Pfizer may pounce next. ...
Pfizer-Allergan: what is a tax inversion deal and why do firms do them? image
Source : Guardian [Read Article] Wednesday 6th of April 2016 06:36:48 PM
....In some cases, that would take the predator company over the 60% threshold by notionally reducing the size of its takeover target. This particularly impacts Pfizer because Allergan has been built through a series of deals. ...
Biggest ever drug deal collapses after US closes tax loopholes image
Source : Daily Express [Read Article] Wednesday 6th of April 2016 01:31:00 PM
. American drugmaker Pfizer was on course to merge with Irish rival Allergan in a £113billion agreement, which would have allowed the US-based company to switch to Ireland's lower corporate rates. ...
Pfizer-Allergan merger collapse reveals real motivation behind tie-up image
Source : Guardian [Read Article] Wednesday 6th of April 2016 12:59:54 PM
....It was poised to be the biggest pharmaceuticals merger ever. Pfizer, the company responsible for Viagra, was to hook up with Botox maker Allergan in a deal worth $160bn (£114bn). ...
Pfizer's merger collapse prompts speculation it will seek new takeover image
Source : Guardian [Read Article] Wednesday 6th of April 2016 12:31:01 PM
. Barack Obama’s derailment of Pfizer’s $160bn (£114bn) merger with Allergan sparked immediate speculation on Wednesday that the US drugs company would turn its attention to another big pharmaceutical takeover. ...
Drugs firms lead FTSE 100 rebound image
Source : BBC [Read Article] Wednesday 6th of April 2016 10:03:58 AM
....63 having fallen more than 1% on Tuesday. Pharmaceutical shares were higher after Pfizer confirmed it had scrapped its planned merger with Allergan. ...
Pfizer scraps $160bn Allergan deal image
Source : BBC [Read Article] Wednesday 6th of April 2016 09:44:20 AM
. US drugs giant Pfizer has scrapped a planned merger with Ireland's Allergan amid plans to change US tax laws. ...
EasyJet slips after update but Shire climbs as deal concerns fade image
Source : Guardian [Read Article] Wednesday 6th of April 2016 09:26:29 AM
....69. The pharmaceuticals group has been under pressure on fears that the US tax inversion rules which has scuppered Pfizer’s deal to buy Allegan could damage Shire’s merger with Baxalta. ...
FTSE rises as Pfizer deal collapses - live updates image
Source : Guardian [Read Article] Wednesday 6th of April 2016 07:19:33 AM
...
Related to :
Pfizer formally abandons $160bn Allergan deal after US tax inversion clampdown image
. The largest pharmaceuticals merger in history, between Pfizer and Allergan, has been abandoned after the US government took fresh steps to clamp down on tax avoidance deals. ...
Obama: Tax avoidance is a big problem image
Source : BBC [Read Article] Tuesday 5th of April 2016 06:46:09 PM
.... . Shares of Allergan fell 16% after the Treasury announcement, as investors feared the new rules would lead Pfizer to abandon its $160bn inversion deal with the Irish-based firm. ...
GlaxoSmithKline to lower drug prices in poorer countries image
Source : Guardian [Read Article] Thursday 31st of March 2016 02:23:00 PM
....Witty said the new tiered model on intellectual property was analogous to GSK’s pricing on vaccines. However, the company, along with US group Pfizer, has come under fire from MSF, which has criticised high prices for new vaccines and called on the firms to reduce the price of the pneumococcal conjugate vaccine to $5 a child in developing countries. ...
How antibiotic resistance could wreak havoc on health, food and travel image
. In January, a coalition of 85 biotechnology, pharmaceutical and diagnostics companies, including Johnson & Johnson and Pfizer, came together at the World Economic Forum in Davos to form a landmark agreement to help combat antibiotic resistance. ...
Carbon emissions: here's what we can do to hit 'science-based targets' image
Source : Guardian [Read Article] Tuesday 23rd of February 2016 06:25:08 PM
.... The initiative reviews and approves the targets set by participating companies, which have two years after signing up to come up with a game plan. So far, the initiative has approved plans from 12 companies, including Dell, Kellogg, NRG Energy and Pfizer. ...
Pharma's woes: profits, policies and patients as NHS England tries to save money on drugs image
.... As with most industrial disputes neither side has a monopoly of virtue, so let’s skip to another corner of the galactic health empire over which Emperor Jeremy and his Darth Vader, Simon Stevens, rule. What, on planet Earth, is Pfizer up to?. ...
'I would not want to be a cancer patient in England' says Pfizer boss image
Source : Telegraph [Read Article] Wednesday 10th of February 2016 06:01:25 PM
.... . Erik Nordkamp, managing director of Pfizer UK, said the Government's proposals on reforming the cancer drugs fund would end up failing patients and “set the clock back five years”. ...
GSK investors split over break-up calls image
Source : Telegraph [Read Article] Saturday 6th of February 2016 07:10:24 PM
.... A top 10 shareholder said: “If he’s fundamentally doing the wrong things, maybe there’s a reason [to change the chief executive] but if things are going slower than expected but are moving in the right direction why should that matter?” . Mr Marwood and other investors have said that GSK should buy out Pfizer and Shionogi of Japan, who hold minority interests in its HIV therapy company, ViiV, and also the consumer health joint venture with Novartis. ...
Questor share tip: AstraZeneca faces Crestor crunch in year ahead image
Source : Telegraph [Read Article] Friday 5th of February 2016 07:00:54 AM
.... . The outlook may be tough but the optimism over the new drug pipeline was previously underlined by the fact US rival Pfizer was willing to pay £55 per share for AstraZeneca in 2014 – Astra rejected the bid. ...
AstraZeneca warns of lower profits as generic competition grows image
Source : Telegraph [Read Article] Thursday 4th of February 2016 03:33:38 PM
.... . The company, which rejected a $120bn takeover bid from US rival Pfizer last year, is in the middle of a big restructuring programme and is trying to rebuild a portfolio of exclusive medicines in oncology, respiratory and cardiovascular/diabetes diseases, amid intense competition from generic drug makers. ...
AstraZeneca warns of declining profits image
Source : Guardian [Read Article] Thursday 4th of February 2016 01:46:14 PM
....3% to £42. 20, well below the £55 a share price offered by the US drugmaker Pfizer nearly two years ago when it tried to take over the group in a £70bn deal. ...
Crestor-owner warns of declining profits image
Source : BBC [Read Article] Thursday 4th of February 2016 07:37:49 AM
....AstraZeneca expects to lose exclusive rights to Crestor in the US in May. The company managed to repel a takeover from its US rival Pfizer in 2014, but its share price is still well below the £55 a share it was offered. ...
Big Pharma's big gamble may prompt a big headache image
Source : Guardian [Read Article] Monday 11th of January 2016 07:36:18 PM
....Whatever Shire’s tax advisers say, the deal will be viewed by many in Washington as further evidence of the pharmaceutical industry’s obsession with minimising US tax payments. Only six weeks ago Pfizer, the giant firm that is American as apple pie, said it would move its headquarters to Dublin after agreeing a “merger” with Allergan, the Botox firm that is cosmetically Irish. ...
Shire clinches $32bn takeover of Baxalta image
Source : Guardian [Read Article] Monday 11th of January 2016 01:45:22 PM
....source: Thomson Reuters (figures include debt). November 2015: Pfizer (US) agreed to buy Actavis/Allergan (US) for $192bn. ...
Shire to combine with Baxalta in £22bn deal image
Source : Telegraph [Read Article] Monday 11th of January 2016 12:53:03 PM
.... . Last year, pharmaceuticals companies racked up more than $550bn worth of M&A deals, capped off by the $160bn blockbuster merger between US-based Pfizer and Dublin-domiciled Allergan in December. ...
Record year for mergers as technology and drugs firm launch spending spree image
Source : Telegraph [Read Article] Friday 18th of December 2015 02:00:32 PM
.... . Pfizer's purchase of Allergan is the biggest takeover of the year  Photo: Bloomberg. ...
GSK buys HIV medicines for $1.4bn image
Source : BBC [Read Article] Friday 18th of December 2015 01:06:55 PM
.... . AstraZeneca, which last year saw off a £69bn takeover bid from US rival Pfizer, also announced it would acquire a number of respiratory medicines from Japan's Takeda for $575m. ...
GlaxoSmithKline buys Bristol-Myers Squibb HIV assets for up to $1.46bn image
Source : Telegraph [Read Article] Friday 18th of December 2015 09:59:52 AM
.... . Last month it was reported that GSK had been approached by Pfizer about a possible takeover, although CEO Andrew Witty refused to comment on the speculation. ...
Raised interest rates may end biggest merger boom the world has ever seen image
Source : Guardian [Read Article] Thursday 17th of December 2015 12:00:04 PM
.... The announcement early this month of the $130bn mega-merger of chemicals behemoths Dow and DuPont will make Skadden, Arps, Slate, Meagher & Flom the first law firm ever to advise clients on deals worth more than $1trn. Indeed, this year has been a windfall for everyone serving the thousands of businesses that have succumbed to M&A mania, from giants like Pfizer, Dell and Anheuser Busch InBev, to smaller businesses like Keurig Green Mountain or China’s Shanghai STO Express Co. ...

Page rendered in 2.0437 seconds.